Xeltis’ restorative technology at Biomaterials

2019-06-11T12:52:57+00:00April 3rd, 2019|Latest News|

Preclinical data on Xeltis’ restorative heart valves will illustrate supramolecular materials’ potential application in clinical practice at the Society for Biomaterials annual meeting on Thursday 4 April. Xeltis CTO Martijn Cox will present 2-year preclinical data outlining the capability [...]

Xeltis’ RestoreX™ in Cardiovascular Pathology

2019-06-11T12:55:58+00:00March 8th, 2019|Latest News|

Peer-reviewed journal Cardiovascular Pathology published positive one-year in-vivo data on Xeltis’ RestoreX™ technology platform in its latest issue. According to the paper, preclinical results of RestoreX™ pulmonary graft confirmed the potential of Xeltis’ restorative cardiovascular approach. The study showed that [...]

Xeltis’ new leadership functional to next phase

2019-06-11T12:58:38+00:00March 1st, 2019|Latest News|

Mohammed El-Kurdi, PhD, Vice President for Tissue Science, and Luc Verhees, Senior Vice President for Clinical, Pre-clinical and Medical Affairs, joined Acting CEO Eliane Schutte - Xeltis CDO since 2016 - and CTO and Co-founder Martijn Cox on Xeltis’ leadership [...]

Children’s Hospital Los Angeles joins the Xplore-2 Study

2019-02-11T17:27:22+00:00June 22nd, 2018|Latest News|

Children’s Hospital Los Angeles (CHLA) recently joined other prominent U.S. pediatric centers in the Xplore-2 clinical research study. The medical institutions that may enroll patients in the Xplore-2 Early Feasibility Study also include: Boston Children’s Hospital, Children’s Healthcare of [...]

Preliminary Xplore-1 data show promise at ECHSA

2018-06-01T15:20:20+00:00June 1st, 2018|Latest News|

Preliminary one-year data from the Xplore-1 clinical trial have shown that Xeltis’ restorative pulmonary heart valve has potential for use in RVOT reconstruction. In a presentation at the ECHSA meeting in Cascais, Portugal, trial investigator Professor Tomasz Mroczek from the [...]

Preliminary Xplore-1 data at ECHSA

2018-05-30T00:15:47+00:00May 30th, 2018|Latest News|

Preliminary one-year data from the Xplore-1 clinical trial, evaluating Xeltis’ restorative pulmonary heart, valve will be presented for the first time at the ECHSA meeting in Cascais, Portugal. Trial investigator Professor Tomasz Mroczek from the Children’s University Hospital, Krakow, Poland, [...]

Load More Posts